Practical and Effective Diagnostic Hematopathology
In-Person Event
May 02 - 05, 2016
La Jolla, California, USASpeakers
OVERVIEW
Practical and Effective Diagnostic Hematopathology is organized by American Society for Clinical Pathology (ASCP) and would be held during May 2 - 5, 2016 at La Jolla, San Diego, California, United States of America. The targeted audience for this medical event basically for Pathologists, Pathology Residents, and Pathologists’ Assistants.
You will gain the latest information on a wide variety of testing methods currently being introduced into practice, plus you’ll discover cutting edge technology that will be available in the near future. Special emphasis will be placed on preparing you for a complete “team” approach to patient management--highlighting the pathologist’s role in diagnosis, prognosis, and therapeutic choices—in order to provide the best possible patient care.
Following this course, you will be able to:
• Describe the genetic and molecular evaluation of myeloid and lymphoid disorders.
• Discuss the utilization of ancillary studies in the diagnosis of myeloid disorders and lymphoid lesions.
• Evaluate lymph node architecture to provide appropriate differential diagnosis for neoplastic and benign conditions.
• Discuss the key features relative to accurate diagnosis and new therapies for the myeloid disorders.
• Explain the key histopathologic features and ancillary testing necessary for effective classification of low grade B cell lymphoma, high grade B cell lymphoma, and Hodgkin lymphoma.
• Apply appropriately the WHO 2008 classification schemes for malignancies affecting primarily the bone marrow and for the various lymphomas.
• Avoid pitfalls in the immunophenotyping of hematolymphoid proliferations.
• Explain the key features of common and uncommon histiocytic disorders.
• Discuss key diagnostic and immunohistochemical features of common splenic pathology.
You will gain the latest information on a wide variety of testing methods currently being introduced into practice, plus you’ll discover cutting edge technology that will be available in the near future. Special emphasis will be placed on preparing you for a complete “team” approach to patient management--highlighting the pathologist’s role in diagnosis, prognosis, and therapeutic choices—in order to provide the best possible patient care.
Following this course, you will be able to:
• Describe the genetic and molecular evaluation of myeloid and lymphoid disorders.
• Discuss the utilization of ancillary studies in the diagnosis of myeloid disorders and lymphoid lesions.
• Evaluate lymph node architecture to provide appropriate differential diagnosis for neoplastic and benign conditions.
• Discuss the key features relative to accurate diagnosis and new therapies for the myeloid disorders.
• Explain the key histopathologic features and ancillary testing necessary for effective classification of low grade B cell lymphoma, high grade B cell lymphoma, and Hodgkin lymphoma.
• Apply appropriately the WHO 2008 classification schemes for malignancies affecting primarily the bone marrow and for the various lymphomas.
• Avoid pitfalls in the immunophenotyping of hematolymphoid proliferations.
• Explain the key features of common and uncommon histiocytic disorders.
• Discuss key diagnostic and immunohistochemical features of common splenic pathology.
KEY DATES
02 May, 2016
Event Start Date
05 May, 2016
Event End Date
SPECIALITIES
HematopathologyPathologySUGGESTED HOTELS
CONFERENCE VENUE
TBD
Quick Links